Evidence map›Paper›PMID 40206102›Full record

ArticleHead and Neck Tumor Segmentation for MR-Guided Applications : First MICCAI Challenge, HNTS-MRG 2024, held in conjunction with MICCAI 2024, Marrakesh, Morocco, October 17, 2024, proceedings2025

Head and Neck Tumor Segmentation on MRIs with Fast and Resource-Efficient Staged nnU-Nets.

Elias Tappeiner, Christian Gapp, Martin Welk, Rainer Schubert

Abstract read
In one paragraph

Article in Head and Neck Tumor Segmentation for MR-Guided Applications : First MICCAI Challenge, HNTS-MRG 2024, held in conjunction with MICCAI 2024, Marrakesh, Morocco, October 17, 2024, proceedings, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Overview of the Head and Neck Tumor Segmentation for Magnetic Resonance Guided Applications (HNTS-MRG) 2024 Challenge.Head and Neck Tumor Segmentation for MR-Guided Applications : First MICCAI Challenge, HNTS-MRG 2024, held in conjunction with MICCAI 2024, Marrakesh, Morocco, October 17, 2024, proceedings · 2025
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Elias TappeinerUMIT Tirol - Private University for Health Sciences and Health Technology, Eduard-Wallnöfer-Zentrum 1, Hall in Tirol 6060, Austria.ORCID 0000-0003-1034-8361
Christian GappUMIT Tirol - Private University for Health Sciences and Health Technology, Eduard-Wallnöfer-Zentrum 1, Hall in Tirol 6060, Austria.ORCID 0000-0002-4520-298X
Martin WelkUMIT Tirol - Private University for Health Sciences and Health Technology, Eduard-Wallnöfer-Zentrum 1, Hall in Tirol 6060, Austria.ORCID 0000-0002-6268-7050
Rainer SchubertUMIT Tirol - Private University for Health Sciences and Health Technology, Eduard-Wallnöfer-Zentrum 1, Hall in Tirol 6060, Austria.ORCID 0000-0002-8026-7500

Funding

Development of functional magnetic resonance imaging-guided adaptive radiotherapy for head and neck cancer patients using novel MR-Linac deviceR01DE028290 · NIDCR · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI CHRISTODOULEAS, JOHN PAUL, FULLER, CLIFTON DAVID · 2019 to 2023
$4.3M
SCH: Personalized Rescheduling of Adaptive Radiation Therapy for Head & Neck CancerR01CA257814 · NCI · RICE UNIVERSITY · PI FULLER, CLIFTON DAVID, SCHAEFER, ANDREW J · 2021 to 2024
$1.8M
NCI NIH HHS R01 CA257814NIDCR NIH HHS R01 DE028290
6 · The paper itself

Abstract

MRI-guided radiotherapy (RT) planning offers key advantages over conventional CT-based methods, including superior soft tissue contrast and the potential for daily adaptive RT due to the reduction of the radiation burden. In the Head and Neck (HN) region labor-intensive and time-consuming tumor segmentation still limits full utilization of MRI-guided adaptive RT. The HN Tumor Segmentation for MR-Guided Applications 2024 challenge (HNTS-MRG) aims to improve automatic tumor segmentation on MRI images by providing a dataset with reference annotations for the tasks of pre-RT and mid-RT planning. In this work, we present our approach for the HNTS-MRG challenge. Based on the insights of a thorough literature review we implemented a fast and resource-efficient two-stage segmentation method using the nnU-Net architecture with residual encoders as a backbone. In our two-stage approach we use the segmentation results of a first training round to guide the sampling process for a second refinement stage. For the pre-RT task, we achieved competitive results using only the first-stage nnU-Net. For the mid-RT task, we could significantly increase the segmentation performance of the basic first stage nnU-Net by utilizing the prior knowledge of the pre-RT plan as an additional input for the second stage refinement network. As team alpinists we achieved an aggregated Dice Coefficient of 80.97 for the pre-RT and 69.84 for the mid-RT task on the online test set of the challenge. Our code and trained model weights for the two-stage nnU-Net approach with residual encoders are available at https://github.com/elitap/hntsmrg24.

Indexed as

Head and Neck TumorMRIsegmentationstaged nnU-Net

Identifiers

PMID40206102
PMCPMC11979668

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.